Company Search:
Advanced Search
Sponsored Links
Oragenics, Inc. Company Snapshot
Oragenics, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oragenics with three other companies in this sector in the United States: Ampio Pharmaceuticals, Incorporation (2015 sales of $1.16 million of which 100% was Pharmaceutical Drugs), Pulmatrix Inc ($1.20 million ), and Sarepta Therapeutics Incorporated ($1.25 million of which 100% was Grants & Research).

Sales Analysis. Oragenics reported sales of $1.18 million for the year ending December of 2015. This represents an increase of 25.1% versus 2014, when the company's sales were $939,926.00 .
  Stock Performance Chart for Oragenics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .17
(Figures in U.S. Dollars)
1 Week -27.5%   13 Weeks -39.2%  
4 Weeks -53.4%   52 Weeks -74.2%  
Oragenics, Inc. Key Data:
  Ticker: OGEN Country: United States
  Exchanges: PAR OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,175,841
(Year Ending Jan 2016).
Employees: 13
  Currency: U.S. Dollars Market Cap: 8,381,545
  Fiscal Yr Ends: December Shares Outstanding: 49,274,219
  Share Type: Common Closely Held Shares: 18,865,288
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.